CSPC Pharmaceutical Group...

OTC: CSPCY · Real-Time Price · USD
5.56
0.15 (2.77%)
At close: Aug 15, 2025, 3:58 PM
5.41
-2.70%
After-hours: Aug 13, 2025, 08:00 PM EDT

CSPC Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.78B 12.02B 10.15B 11.36B
Short-Term Investments
1.47B 1.08B 3.52B 1.77B
Long-Term Investments
4.8B 4.64B 3.73B 4.42B
Other Long-Term Assets
1.53B 203.75M 553.73M 513.63M
Receivables
9.94B 10.13B 6.69B 7.98B
Inventory
3.13B 3.14B 2.52B 3.03B
Other Current Assets
362.35M n/a 6B 6.55B
Total Current Assets
21.89B 26.74B 23.62B 24.88B
Property-Plant & Equipment
13.08B 12.26B 10.82B 11.7B
Goodwill & Intangibles
2.84B 2.43B 2.34B 939.25M
Total Long-Term Assets
22.5B 19.54B 17.56B 17.62B
Total Assets
44.39B 46.28B 41.18B 42.5B
Account Payables
2.61B 2.84B 1.77B 1.62B
Deferred Revenue
n/a -8.31M 788.16M 524.05M
Short-Term Debt
392.2M 450.22M 291.38M n/a
Other Current Liabilities
945.86M 827.12M 1.63B 645.75M
Total Current Liabilities
9.63B 10.18B 8.83B 8.84B
Long-Term Debt
n/a n/a 25.42M n/a
Other Long-Term Liabilities
407.81M 399.68M 67.04M 12.42M
Total Long-Term Liabilities
888.67M 1.08B 886.28M 534.69M
Total Liabilities
10.52B 11.26B 9.72B 9.37B
Total Debt
507.33M 706.9M 574.32M 115.04M
Common Stock
11.03B 11.99B 10.75B 13.33B
Retained Earnings
23.34B 26.46B 20.84B 21.13B
Comprehensive Income
n/a n/a -1.73B -2.57B
Shareholders Equity
32.26B 30.07B 29.77B 31.79B
Total Investments
6.27B 5.72B 7.25B 6.18B